Annual EBIT:
-$196.13M+$370.80M(+65.41%)Summary
- As of today, PTCT annual earnings before interest & taxes is -$196.13 million, with the most recent change of +$370.80 million (+65.41%) on December 31, 2024.
- During the last 3 years, PTCT annual EBIT has risen by +$236.19 million (+54.63%).
- PTCT annual EBIT is now -741.31% below its all-time high of $30.58 million, reached on December 31, 2011.
Performance
PTCT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$40.69M-$1.00B(-104.22%)Summary
- As of today, PTCT quarterly earnings before interest & taxes is -$40.69 million, with the most recent change of -$1.00 billion (-104.22%) on June 30, 2025.
- Over the past year, PTCT quarterly EBIT has increased by +$1.55 million (+3.67%).
- PTCT quarterly EBIT is now -104.22% below its all-time high of $963.92 million, reached on March 31, 2025.
Performance
PTCT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$813.21M+$1.55M(+0.19%)Summary
- As of today, PTCT TTM earnings before interest & taxes is $813.21 million, with the most recent change of +$1.55 million (+0.19%) on June 30, 2025.
- Over the past year, PTCT TTM EBIT has increased by +$1.15 billion (+341.08%).
- PTCT TTM EBIT is now at all-time high.
Performance
PTCT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PTCT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +65.4% | +3.7% | +341.1% |
| 3Y3 Years | +54.6% | +67.9% | +279.5% |
| 5Y5 Years | +13.8% | +76.9% | +319.4% |
PTCT EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +65.4% | -104.2% | +80.4% | at high | +231.3% |
| 5Y | 5-Year | at high | +65.4% | -104.2% | +80.4% | at high | +231.3% |
| All-Time | All-Time | -741.3% | +65.4% | -104.2% | +80.4% | at high | +231.3% |
PTCT EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$40.69M(-104.2%) | $813.21M(+0.2%) |
| Mar 2025 | - | $963.92M(+1897.1%) | $811.66M(+513.8%) |
| Dec 2024 | -$196.13M(+65.4%) | -$53.64M(+4.9%) | -$196.13M(+23.2%) |
| Sep 2024 | - | -$56.38M(-33.5%) | -$255.26M(+24.3%) |
| Jun 2024 | - | -$42.24M(+3.7%) | -$337.31M(+33.0%) |
| Mar 2024 | - | -$43.86M(+61.1%) | -$503.13M(+11.3%) |
| Dec 2023 | -$566.93M(-14.2%) | -$112.78M(+18.5%) | -$566.93M(+8.5%) |
| Sep 2023 | - | -$138.43M(+33.5%) | -$619.35M(-5.5%) |
| Jun 2023 | - | -$208.06M(-93.3%) | -$587.24M(-16.1%) |
| Mar 2023 | - | -$107.66M(+34.8%) | -$505.90M(-1.9%) |
| Dec 2022 | -$496.62M(-14.9%) | -$165.19M(-55.4%) | -$496.62M(-11.0%) |
| Sep 2022 | - | -$106.33M(+16.1%) | -$447.53M(+1.2%) |
| Jun 2022 | - | -$126.72M(-28.8%) | -$453.06M(-7.4%) |
| Mar 2022 | - | -$98.38M(+15.3%) | -$421.66M(+2.5%) |
| Dec 2021 | -$432.32M(-24.7%) | -$116.11M(-3.8%) | -$432.32M(-22.2%) |
| Sep 2021 | - | -$111.86M(-17.3%) | -$353.64M(-31.9%) |
| Jun 2021 | - | -$95.32M(+12.6%) | -$268.15M(+23.1%) |
| Mar 2021 | - | -$109.03M(-191.3%) | -$348.79M(-0.6%) |
| Dec 2020 | -$346.58M(-52.4%) | -$37.43M(-42.0%) | -$346.58M(+6.5%) |
| Sep 2020 | - | -$26.36M(+85.0%) | -$370.72M(+7.8%) |
| Jun 2020 | - | -$175.96M(-64.7%) | -$402.03M(-51.7%) |
| Mar 2020 | - | -$106.82M(-73.5%) | -$265.01M(-16.5%) |
| Dec 2019 | -$227.44M(-96.8%) | -$61.57M(-6.8%) | -$227.44M(-7.9%) |
| Sep 2019 | - | -$57.67M(-48.1%) | -$210.87M(-4.7%) |
| Jun 2019 | - | -$38.94M(+43.8%) | -$201.43M(-19.9%) |
| Mar 2019 | - | -$69.25M(-53.9%) | -$168.06M(-45.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$115.56M(-79.7%) | -$45.01M(+6.7%) | -$115.56M(-77.5%) |
| Sep 2018 | - | -$48.23M(-765.3%) | -$65.10M(-36.3%) |
| Jun 2018 | - | -$5.57M(+66.7%) | -$47.76M(+12.7%) |
| Mar 2018 | - | -$16.74M(-407.2%) | -$54.68M(+15.0%) |
| Dec 2017 | -$64.29M(+51.3%) | $5.45M(+117.6%) | -$64.29M(+32.1%) |
| Sep 2017 | - | -$30.89M(-147.2%) | -$94.74M(+1.2%) |
| Jun 2017 | - | -$12.50M(+52.6%) | -$95.91M(+20.1%) |
| Mar 2017 | - | -$26.36M(-5.5%) | -$119.97M(+9.2%) |
| Dec 2016 | -$132.06M(+21.0%) | -$24.99M(+22.1%) | -$132.06M(+14.9%) |
| Sep 2016 | - | -$32.06M(+12.3%) | -$155.27M(+6.1%) |
| Jun 2016 | - | -$36.56M(+4.9%) | -$165.44M(+1.2%) |
| Mar 2016 | - | -$38.44M(+20.2%) | -$167.50M(-0.2%) |
| Dec 2015 | -$167.13M(-68.1%) | -$48.20M(-14.1%) | -$167.13M(-10.6%) |
| Sep 2015 | - | -$42.23M(-9.3%) | -$151.16M(-10.7%) |
| Jun 2015 | - | -$38.63M(-1.5%) | -$136.53M(-10.8%) |
| Mar 2015 | - | -$38.07M(-18.1%) | -$123.27M(-24.0%) |
| Dec 2014 | -$99.41M(-119.0%) | -$32.23M(-16.8%) | -$99.41M(-16.6%) |
| Sep 2014 | - | -$27.60M(-8.8%) | -$85.28M(-37.7%) |
| Jun 2014 | - | -$25.37M(-78.5%) | -$61.95M(-21.4%) |
| Mar 2014 | - | -$14.21M(+21.5%) | -$51.03M(-12.4%) |
| Dec 2013 | -$45.40M(-69.3%) | -$18.09M(-323.1%) | -$45.40M(-36.2%) |
| Sep 2013 | - | -$4.28M(+70.4%) | -$33.34M(-14.7%) |
| Jun 2013 | - | -$14.45M(-68.5%) | -$29.06M(-98.9%) |
| Mar 2013 | - | -$8.58M(-42.1%) | -$14.61M(-19.7%) |
| Dec 2012 | -$26.81M(-187.7%) | -$6.03M(+2.2%) | -$12.21M(-97.8%) |
| Mar 2012 | - | -$6.17M | -$6.17M |
| Dec 2011 | $30.58M | - | - |
FAQ
- What is PTC Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. annual EBIT year-on-year change?
- What is PTC Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is PTC Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. TTM EBIT year-on-year change?
What is PTC Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of PTCT is -$196.13M
What is the all-time high annual EBIT for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high annual earnings before interest & taxes is $30.58M
What is PTC Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, PTCT annual earnings before interest & taxes has changed by +$370.80M (+65.41%)
What is PTC Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of PTCT is -$40.69M
What is the all-time high quarterly EBIT for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $963.92M
What is PTC Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, PTCT quarterly earnings before interest & taxes has changed by +$1.55M (+3.67%)
What is PTC Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of PTCT is $813.21M
What is the all-time high TTM EBIT for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $813.21M
What is PTC Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, PTCT TTM earnings before interest & taxes has changed by +$1.15B (+341.08%)